Lirafugratinib [2549174-42-5]

MedChem Express

Lirafugratinib [2549174-42-5]

10

2549174-42-5

Research Use Only

99.67

C28H24FN7O2

509.53

Lirafugratinib (RLY-4008) is an orally active, irreversible and highly selective FGFR2 inhibitor with an IC50 of 3 nM. Lirafugratinib covalently binds to Cys491. Lirafugratinib targets FGFR2 primary alterations and resistance mutations and induces tumor regression while sparing other FGFRs[1].

O=C(C(C)=C)NC1=CC=C(C2=C(C3=C(N)N=CN=C3N2C)C4=CC(F)=C(OC5=NC=CC(C)=N5)C=C4)C=C1

-20°C,2°C to 8°C

12131703